DrugDashboards

Market view

senna and docusate sodium tablets, 8.6 mg and 50 mg · Tablet, Coated

4 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for senna and docusate sodium tablets, 8.6 mg and 50 mg, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Senna-SSep 2, 2026
    Mfr exited
    HealthLife of USA LLC · senna and docusate sodium tablets, 8.6 mg and 50 mg
  • Senna-SAug 26, 2026
    Mfr entered
    HealthLife of USA LLC · senna and docusate sodium tablets, 8.6 mg and 50 mg
  • Senna-SJul 29, 2026
    Mfr exited
    HealthLife of USA LLC · senna and docusate sodium tablets, 8.6 mg and 50 mg
  • Senna-SJul 22, 2026
    Mfr entered
    HealthLife of USA LLC · senna and docusate sodium tablets, 8.6 mg and 50 mg

Common questions

Is Senna and docusate sodium tablets, 8.6 mg and 50 mg in shortage right now?
No. FDA does not currently list Senna and docusate sodium tablets, 8.6 mg and 50 mg in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Senna and docusate sodium tablets, 8.6 mg and 50 mg?
1 company has marketed Senna and docusate sodium tablets, 8.6 mg and 50 mg in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.